Leptin-Replacement Therapy for Lipodystrophy

Cited by (1,000)

Items 201–300 of 1,000

1. Central nervous system regulation of organismal energy and glucose homeostasis
   Martin Grosvenor Myers, Alison H. Affinati, Nicole E. Richardson, Michael W. Schwartz · 2021 · Nature Metabolism
2. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats
   James R. Levy, John N. Clore, Wayne D. Stevens · 2004 · Hepatology
3. Genetic disorders of adipose tissue development, differentiation, and death.
   Agarwal, Anil K., Garg, Abhimanyu · 2006 · Annual Review of Genomics and Human Genetics
4. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice
   Young Lee, R. Haris Naseem, Laurence Duplomb, Byung‐Hyun Park, Daniel J. Garry, James A. Richardson, Jean E. Schaffer, Roger H. Unger · 2004 · Proceedings of the National Academy of Sciences
5. Brain Adipocytokine Action and Metabolic Regulation
   Ahima, Rexford S., Qi, Yong, Singhal, Neel S., Jackson, Malaka B., Scherer, Philipp E. · 2006 · Diabetes
6. Transplantation of Adipose Tissue Lacking Leptin Is Unable to Reverse the Metabolic Abnormalities Associated With Lipoatrophy
   Colombo, Carlo, Cutson, Jaime J., Yamauchi, Toshimasa, Vinson, Charles, Kadowaki, Takashi, Gavrilova, Oksana, Reitman, Marc L. · 2002 · Diabetes
7. Efficacy of metreleptin in obese patients with type 2 diabetes: Cellular and molecular pathways underlying leptin tolerance
   Moon, Hyun-Seuk, Matarese, Giuseppe, Brennan, Aoife M., Chamberland, John P., Liu, Xiaowen, Fiorenza, Christina G., Mylvaganam, Geetha H., Abanni, Luisa, Carbone, Fortunata, Williams, Catherine J. et al. · 2011 · Diabetes
8. Genomic insights into the causes of type 2 diabetes
   Claudia Langenberg, Luca Andrea Lotta · 2018 · The Lancet
9. The role of leptin in glucose homeostasis
   Heather C. Denroche, Frank K. Huynh, Timothy J. Kieffer · 2012 · Journal of Diabetes Investigation
10. Obesity and cancer, a case for insulin signaling
    Yekaterina Poloz, Vuk Stambolic · 2015 · Cell Death and Disease
11. Does Leptin Play A Role in The Pathogenesis of Human Nonalcoholic Steatohepatitis?
    Naga Chalasani, David W. Crabb, Oscar W. Cummings, Paul Yien Kwo, Ali Asghar, Prashant Pandya, Robert V. Considine · 2003 · The American Journal of Gastroenterology
12. Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue.
    N. Rasouli, U. Raue, L. M. Miles, T. Lu, G. D. Di Gregorio, S. Elbein, P. Kern · 2005 · American Journal of Physiology. Endocrinology and Metabolism
13. Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance
    Eunjung Lee, Dae Young Jung, Jong Hun Kim, Payal R. Patel, Xiaodi Hu, Yongjin Lee, Yoshihiro Azuma, Hsun-Fan Wang, Nicholas Tsitsilianos, Umber Shafiq et al. · 2015 · The FASEB Journal
14. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients
    Musso, Carla, Cochran, Elaine, Javor, Edward, Young, Janice, DePaoli, Alex M., Gorden, Phillip · 2005 · Metabolism
15. Genetic Basis of Lipodystrophies and Management of Metabolic Complications
    Anil K. Agarwal, Abhimanyu Garg · 2006 · Annual Review of Medicine
16. Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
    Jean Lin Chan, Karen Lutz, Elaine K. Cochran, Wenying Huang, Yvette Peters, Christian Weyer, Phillip Görden · 2011 · Endocrine Practice
17. Metabolic Actions of Adipocyte Hormones: Focus on Adiponectin
    Rexford S. Ahima · 2006 · Obesity
18. Keynote review: The adipocyte as a drug discovery target
    Andrea R. Nawrocki, Philipp E. Scherer · 2005 · Drug Discovery Today
19. Emerging Therapeutic Strategies for Obesity
    Karen E. Foster‐Schubert, David E. Cummings · 2006 · Endocrine Reviews
20. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation
    A. Nawrocki · 2004 · Current Opinion in Pharmacology
21. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy
    Rebecca J. Brown, Elif A Oral, Elaine K. Cochran, David Araújo‐Vilar, David B. Savage, Alison Long, Gregory Fine, Taylor C. Salinardi, Phillip Görden · 2018 · Endocrine
22. The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease
    Sarah N. Framnes‐DeBoer, Deanna Marie Arble · 2018 · Frontiers in Endocrinology
23. Lipodystrophies: rare disorders causing metabolic syndrome
    Abhimanyu Garg, Anoop Misra · 2004 · Endocrinology and Metabolism Clinics of North America
24. The Use of U-500 in Patients With Extreme Insulin Resistance
    Elaine K. Cochran, Carla Musso, Phillip Görden · 2005 · Diabetes Care
25. Adipose tissue as an endocrine organ: impact on insulin resistance.
    Jazet Im, Hanno Pijl, Meinders Ae · 2003 · PubMed
26. There and Back Again: Leptin Actions in White Adipose Tissue
    Noelia Martínez‐Sánchez · 2020 · International Journal of Molecular Sciences
27. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression
    Alexander Rupert Moschen, Clemens Molnar, Anna Maria Wolf, Helmut G Weiss, Ivo W. Graziadei, Susanne Kaser, Christoph F. Ebenbichler, Sylvia Stadlmann, Patrizia Lucia Moser, Herbert Tilg · 2009 · Journal of Hepatology
28. Pathogenesis of NASH: the Impact of Multiple Pathways
    Mazen Noureddin, Arun Jayant Sanyal · 2018 · Current Hepatology Reports
29. Hepatic Steatosis, Insulin Resistance, and Adipose Tissue Disorders
    Abhimanyu Garg, Anoop Misra · 2002 · The Journal of Clinical Endocrinology & Metabolism
30. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
    Stefanakis, Konstantinos, Kokkorakis, Michail, Mantzoros, Christos S. · 2024 · Metabolism
31. Effects of HIV protease inhibitor therapy on lipid metabolism
    David Y. Hui · 2003 · Progress in Lipid Research
32. Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors
    Robert K. Semple, Maria A. Soos, Jian’an Luan, Courtney Mitchell, J. C. Wilson, Mark Gurnell, Elaine K. Cochran, Phillip Görden, Krishna Chatterjee, Nicholas J. Wareham et al. · 2006 · The Journal of Clinical Endocrinology & Metabolism
33. Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance
    Junhong Gao, Hideki Katagiri, Yasushi Ishigaki, Tetsuya Yamada, Takehide Ogihara, Junta Imai, Kenji Uno, Yutaka Hasegawa, Makoto Kanzaki, Tokuo T. Yamamoto et al. · 2006 · Diabetes
34. Molecular mechanisms of central leptin resistance in obesity
    Chang Hee Jung, Min-Seon Kim · 2013 · Archives of Pharmacal Research
35. Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers
    Cyril Couturier, Ralf Jockers · 2003 · Journal of Biological Chemistry
36. A Regulatory Role for 1-Acylglycerol-3-phosphate-O-acyltransferase 2 in Adipocyte Differentiation
    Sarah E. Gale, Andrey Frolov, Xianlin Han, Perry E. Bickel, Li Cao, Anne M. Bowcock, Jean E. Schaffer, Daniel S. Ory · 2006 · Journal of Biological Chemistry
37. The pleiotropic roles of leptin in metabolism, immunity, and cancer
    Paola de Candia, Francesco Prattichizzo, S. Garavelli, Carlo Alviggi, Antonio La Cava, Giuseppe Matarese · 2021 · The Journal of Experimental Medicine
38. Lipoatrophic diabetes in Irs1−/−/Irs3−/− double knockout mice
    Palle G. Laustsen, M. Dodson Michael, Barbara E. Crute, Shmuel E. Cohen, Kohjiro Ueki, Rohit N. Kulkarni, Susanna R. Keller, Gustav E. Lienhard, C. Ronald Kahn · 2002 · Genes & Development
39. Effects of Exogenous Leptin on Satiety and Satiation in Patients with Lipodystrophy and Leptin Insufficiency
    McDuffie, Jennifer R., Riggs, Patti A., Calis, Karim A., Freedman, Renee J., Oral, Elif A., DePaoli, Alex M., Yanovski, Jack A. · 2004 · The Journal of Clinical Endocrinology & Metabolism
40. Leptin Engages a Hypothalamic Neurocircuitry to Permit Survival in the Absence of Insulin
    Teppei Fujikawa, Eric D. Berglund, Vishal R. Patel, Giorgio Ramadori, Claudia Regina Vianna, Linh Vong, Fabrizio Thorel, Simona Chera, Pedro Luis Herrera, Bradford B. Lowell et al. · 2013 · Cell Metabolism
41. Physiological, pathological and potential therapeutic roles of adipokines
    Inês Falcão‐Pires, Paulo Castro‐Chaves, Daniela Miranda‐Silva, André Pedro Lourenço, Adelino Ferreira Leite-Moreira · 2012 · Drug Discovery Today
42. Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies
    Melvin Khee‐Shing Leow, Carol Addy, Christos Socrates Mantzoros · 2003 · The Journal of Clinical Endocrinology & Metabolism
43. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia
    Mulligan, Kathleen, Khatami, Hootan, Schwarz, Jean-Marc, Sakkas, Giorgos K., DePaoli, Alex M., Tai, Viva W., Wen, Michael J., Lee, Grace A., Grunfeld, Carl, Schambelan, Morris · 2009 · The Journal of Clinical Endocrinology & Metabolism
44. HIV-Associated Facial Lipoatrophy
    Julia James, ALASTAIR J. CARRUTHERS, JEAN D. A. CARRUTHERS · 2002 · Dermatologic Surgery
45. The Role of Muscle Insulin Resistance in the Pathogenesis of Atherogenic Dyslipidemia and Nonalcoholic Fatty Liver Disease Associated with the Metabolic Syndrome
    François R. Jornayvaz, Varman T. Samuel, Gerald I. Shulman · 2010 · Annual Review of Nutrition
46. Effect of Leptin Replacement on Pituitary Hormone Regulation in Patients with Severe Lipodystrophy
    Oral, Elif Arioglu, Ruiz, Elaine, Andewelt, Alexa, Sebring, Nancy, Wagner, Anthony J., Depaoli, Alex M., Gorden, Phillip · 2002 · The Journal of Clinical Endocrinology & Metabolism
47. The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement
    Yehuda Handelsman, Elif A Oral, Zachary T. Bloomgarden, Rebecca J. Brown, Jean Lin Chan, DANIEL F. EINHORN, Alan J. Garber, Abhimanyu Garg, William Timothy Garvey, George Grunberger et al. · 2013 · Endocrine Practice
48. Leptin: Less Is More
    Shangang Zhao, Christine M. Kusminski, Joel Keith Elmquist, Philipp E. Scherer · 2020 · Diabetes
49. Central insulin and leptin-mediated autonomic control of glucose homeostasis
    Joseph S. Marino, Yong Xu, Jennifer Wootton Hill · 2011 · Trends in Endocrinology and Metabolism
50. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome
    Correia, Marcelo L. G., Rahmouni, Kamal · 2006 · Diabetes, Obesity and Metabolism
51. Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio
    Gloria Lena Vega, Scott M. Grundy · 2013 · Journal of Obesity
52. Effect of Leptin Replacement on Intrahepatic and Intramyocellular Lipid Content in Patients With Generalized Lipodystrophy
    Vinaya Simha, Lidia S. Szczepaniak, Anthony J. Wagner, Alex M. DePaoli, Abhimanyu Garg · 2003 · Diabetes Care
53. Angiotensin-(1-7), Adipokines and Inflammation.
    D. de Farias Lelis, Daniela Fernanda de Freitas, A. S. Machado, T. S. Crespo, S. Santos · 2019 · Metabolism: Clinical and Experimental
54. Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity
    Mostafa Wanees Ahmed El Husseny, Mediana Mamdouh, Sara Shaban, Abdelrahman Ibrahim Abushouk, Marwa Mostafa Mohamed Zaki, Osama M. Ahmed, Mohamed M. Abdel‐Daim · 2017 · Journal of Diabetes Research
55. Adipose Tissue: Physiology to Metabolic Dysfunction
    Allison J. Richard, Ursula A. White, Carrie M. Elks, Jacqueline M. Stephens · 2020 · Europe PMC (PubMed Central)
56. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart
    Morris Karmazyn, Daniel M. Purdham, Venkatesh Rajapurohitam, Asad Zeidan · 2008 · Cardiovascular Research
57. Role of leptin resistance in the development of obesity in older patients
    Frédéric Picard, Sophie Carter, Alexandre Caron, Denis Richard · 2013 · Clinical Interventions in Aging
58. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis
    Martina Theresa Hackl, Clemens Fürnsinn, Christina Maria Schuh, Martin Krššák, Fabrizia Carli, Sara Guerra, Angelika Freudenthaler, Sabina M. Baumgartner-Parzer, Thomas H. Helbich, Anton Luger et al. · 2019 · Nature Communications
59. Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
    Stergios A. Pοlyzos, Nikolaos Perakakis, Christos Socrates Mantzoros · 2019 · Metabolism
60. Improved beta-cell function after standardized weight reduction in severely obese subjects.
    M. Guldstrand, Ah-Ren Bo, U. Adamson · 2003 · American Journal of Physiology. Endocrinology and Metabolism
61. Lipodystrophy: lessons in lipid and energy metabolism
    Vinaya Simha, Abhimanyu Garg · 2006 · Current Opinion in Lipidology
62. Proteinuric Nephropathy in Acquired and Congenital Generalized Lipodystrophy: Baseline Characteristics and Course during Recombinant Leptin Therapy
    Javor, Edward D., Moran, Stephanie Ann, Young, Janice Ryan, Cochran, Elaine K., DePaoli, Alex M., Oral, Elif Arioglu, Turman, Martin A., Blackett, Piers R., Savage, David B., O’Rahilly, Stephen et al. · 2004 · The Journal of Clinical Endocrinology & Metabolism
63. Recombinant Human Leptin Treatment Does Not Improve Insulin Action in Obese Subjects With Type 2 Diabetes
    Bettina Mittendorfer, Jeffrey F. Horowitz, Alex M. DePaoli, Mark A. Mccamish, Bruce W. Patterson, Samuel Klein · 2011 · Diabetes
64. Distinct Effects of Leptin and a Melanocortin Receptor Agonist Injected Into Medial Hypothalamic Nuclei on Glucose Uptake in Peripheral Tissues
    Chitoku Toda, Tetsuya Shiuchi, Sai Peck Lee, Maya Yamato-Esaki, Yusuke Fujino, Atsushi Suzuki, Shiki Okamoto, Yasuhiko Minokoshi · 2009 · Diabetes
65. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes
    Guenther H. Boden, Peter Cheung, Maria A. Mozzoli, Susan K. Fried · 2003 · Metabolism
66. Human Immunodeficiency Virus Type 1–Related Lipoatrophy and Lipohypertrophy Are Associated with Serum Concentrations of Leptin
    G. Sonia Nagy, Sotirios Tsiodras, Lizabeth D. Martin, Anchalee Avihingsanon, Alina Gavrila, William C. Hsu, Adolf W. Karchmer, Christos Socrates Mantzoros · 2003 · Clinical Infectious Diseases
67. Adiponectin and Leptin Levels in HIV-Infected Subjects With Insulin Resistance and Body Fat Redistribution
    Dennis C. Mynarcik, Terry P. Combs, Margaret A. McNurlan, Philipp E. Scherer, Eugene Komaroff, Marie C. Gelato · 2002 · JAIDS Journal of Acquired Immune Deficiency Syndromes
68. Adipose tissue as an endocrine organ
    Prins, Johannes B. · 2002 · Best Practice & Research Clinical Endocrinology & Metabolism
69. Human Lipodystrophies: Genetic and Acquired Diseases of Adipose Tissue
    Jacqueline Capeau, Jocelyne Magré, Martine Caron, Claire Lagathu, Bénédicte Antoine, Véronique Béréziat, Olivier Lascols, Jean‐Philippe Bastard, Corinne Vigouroux · 2010 · Endocrine development
70. Mechanisms of obesity-induced metabolic and vascular dysfunctions
    Robert W. Caldwell · 2019 · Frontiers in bioscience
71. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
    Jane Edith Mallewa, E. Wilkins, Javier Vilar, Macpherson Mallewa, Dominic A. Doran, David J. Back, Munir Pirmohamed · 2008 · Journal of Antimicrobial Chemotherapy
72. Role of adipokines in the control of energy metabolism: focus on adiponectin
    Max Lafontan, Nathalie Viguerie · 2006 · Current Opinion in Pharmacology
73. Leptin: obesity, diabetes and other peripheral effects - a review
    O. Moran, Moshe Phillip · 2003 · Pediatric Diabetes
74. Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy
    Jean Y. Park, Edward D. Javor, Elaine K. Cochran, Alex M. DePaoli, Phillip Görden · 2007 · Metabolism
75. Adipokines and cardiovascular disease: A comprehensive review
    Aleš Smékal, Jan Václavík · 2017 · Biomedical Papers
76. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease
    Iram Hussain, Nivedita Patni, Abhimanyu Garg · 2018 · Pathology
77. Long-Term Prospective and Controlled Studies Demonstrate Adipose Tissue Hypercellularity and Relative Leptin Deficiency in the Postobese State
    Patrik Löfgren, Ingalena Andersson, Birgitta Adolfsson, Britt-Marie Leijonhufvud, Katarina Hertel, Johan Hoffstedt, Peter Arner · 2005 · The Journal of Clinical Endocrinology & Metabolism
78. Contribution of adipocyte-derived factors to beta-cell dysfunction in diabetes
    Yu-Feng Zhao, Dan Dan Feng, Chen Chen · 2005 · The International Journal of Biochemistry & Cell Biology
79. Mouse models of inherited lipodystrophy
    David B. Savage · 2009 · Disease Models & Mechanisms
80. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
    Harold Edward Bays, Lawrence Blonde, Robert S. Rosenson · 2006 · Expert Review of Cardiovascular Therapy
81. Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion
    Philippe Cettour-Rose, C. Theander-Carrillo, Cédric S. Asensio, Marcella Klein, Theo J. Visser, Albert Burger, C. A. Meier, Françoise Rohner‐Jeanrenaud · 2005 · Diabetologia
82. Insulin Resistance in the Defense against Obesity
    Alan R. Saltiel · 2012 · Cell Metabolism
83. Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes
    Yuka Toyoshima, Oksana Gavrilova, Shoshana Yakar, William Jou, Stephanie Pack, Zeenat A. Shyr, Michael B. Wheeler, Derek LeRoith · 2005 · Endocrinology
84. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
    Rebecca J. Brown, Arelí Valencia, Megan S Startzell, Elaine K. Cochran, Peter J. Walter, Hugo Martin Garraffo, Hongyi Cai, Ahmed M. Gharib, Ronald Ouwerkerk, Amber B. Courville et al. · 2018 · Journal of Clinical Investigation
85. Severe insulin resistance syndromes
    Angeliki M. Angelidi, Andreas Filippaios, Christos Socrates Mantzoros · 2021 · Journal of Clinical Investigation
86. Obesity and metabolic disease: is adipose tissue the culprit?
    Keith N. Frayn · 2005 · Proceedings of The Nutrition Society
87. Metreleptin: First Global Approval
    Ken Chou, Caroline M. Perry · 2013 · Drugs
88. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey
    Barış Akıncı, Hüseyin Önay, Tevfik Demir, Samim Özen, Hülya Kayserili, Gülçin Akıncı, Banu Guzel Nur, Beyhan Tüysüz, Mehmet Nuri Özbek, Âdem Güngör et al. · 2016 · The Journal of Clinical Endocrinology & Metabolism
89. Obesity, Inflammation, and Vascular Disease
    Paolo Calabrò, Edward T.H. Yeh · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
90. Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet
    Toru Kusakabe, Hideki Tanioka, Ken Ebihara, M. Hirata, Licht Miyamoto, Fumiko Miyanaga, H. Hige, Daisuke Aotani, Tomomi Fujisawa, Hiroaki Masuzaki et al. · 2009 · Diabetologia
91. Cytokines and inflammation in adipogenesis: an updated review
    Ning Jiang, Li Yao, Ting Shu, Jing Wang · 2018 · Frontiers of Medicine
92. Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator–Activated Receptor γ Activation
    A. Yao-Borengasser, N. Rasouli, Vijayalakshmi Varma, L. M. Miles, Bounleut Phanavanh, Tasha Starks, Jack Phan, H. Spencer, R. E. McGehee, K. Reue et al. · 2006 · Diabetes
93. Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
    Wei‐Yi Chen, Églantine Balland, Michael Alexander Cowley · 2017 · Neuroendocrinology
94. AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females
    Steinberg, Gregory R., Smith, Angela C., van Denderen, Bryce J. W., Chen, Zhiping, Murthy, Sid, Campbell, Duncan J., Heigenhauser, G. J. F., Dyck, David J., Kemp, Bruce E. · 2004 · The Journal of Clinical Endocrinology & Metabolism
95. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
    Moran, Stephanie Ann, Patten, Nicole, Young, Janice Ryan, Cochran, Elaine, Sebring, Nancy, Reynolds, James, Premkumar, Ahalya, Depaoli, Alex M, Skarulis, Monica C, Oral, Elif Arioglu et al. · 2004 · Metabolism
96. Leptin and Hormones
    Georgios A. Triantafyllou, Stavroula Α. Paschou, Christos Socrates Mantzoros · 2016 · Endocrinology and Metabolism Clinics of North America
97. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
    Elif A Oral, Phillip Görden, Elaine K. Cochran, David Araújo‐Vilar, David B. Savage, Alison Long, Gregory Fine, Taylor C. Salinardi, Rebecca J. Brown · 2019 · Endocrine
98. Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety
    Vinaya Simha, Lalitha Subramanyam, Lidia S. Szczepaniak, Claudia Quittner, BEVERLEY A. ADAMS-HUET, Peter G Snell, Abhimanyu Garg · 2011 · The Journal of Clinical Endocrinology & Metabolism
99. Pediatric Obesity: Etiology and Treatment
    Melissa K. Crocker, Jack Adam Yanovski · 2009 · Endocrinology and Metabolism Clinics of North America
100. Association of onset of obesity with sleep duration and shift work among Japanese adults
     Osamu Itani, Yoshitaka Kaneita, Atsushi Murata, Eise Yokoyama, Takashi Ohida · 2011 · Sleep Medicine